MQS Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

MQS Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.2K	Sell	11,451 -963	-8%	-$3.95K	0.03%	366
2025 Q4	$41.8K	Buy	+12,414	New	+$32.2K	0.02%	386
2024 Q1	–	Sell	-27,908	Closed	-$319K	–	571
2023 Q4	$319K	Sell	27,908 -1,158	-4%	-$11.5K	0.18%	247
2023 Q3	$280K	Buy	+29,066	New	+$285K	0.17%	265
2022 Q4	–	Sell	-20,729	Closed	-$215K	–	479
2022 Q3	$215K	Buy	20,729 +9,048	+77%	+$103K	0.14%	329
2022 Q2	$135K	Buy	+11,681	New	+$138K	0.09%	344

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MQS Management's IRWD Position: Q1 2026 in Review

MQS Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 7.8% in Q1 2026, selling an estimated $3.95K and leaving 11,451 shares worth $40.2K. The position accounts for 0.03% of the portfolio, ranked #366.

MQS Management first reported a position in IRWD in Q2 2022 and has held it in 6 quarters since. The position peaked at $319K in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

MQS Management held 11,451 shares of Ironwood Pharmaceuticals worth $40.2K as of Q1 2026.
MQS Management sold 963 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $3.95K.
Ironwood Pharmaceuticals made up 0.03% of MQS Management's portfolio in Q1 2026, its #366 holding.
MQS Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and has held it in 6 quarters since.
MQS Management's Ironwood Pharmaceuticals position peaked at $319K in Q4 2023.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.